Headache
- Migraine Treatment Persistence Similar Among Eptinezumab and OnabotulinumtoxinA
- Growing Pains May Be Precursor to Migraine
- Ubrogepant is Effective in Combination With OnabotulinumtoxinA to Treat Migraine
- Galcanezumab Shown Safe and Effective for Migraine in Open-Label Extension
- CGRP Monoclonal Antibodies Not Tied to COVID-19 Risk in Veterans With Migraine
- Four or Fewer Monthly Headache Days Effective Target for Chronic Migraine Treatment
- For Patient Satisfaction, Better Access to Migraine Treatment Is Needed
- Which Medications Work Best for Preventing and Treating Menstrual Migraine?
- Blood Pressure-Lowering Medications Reduce Episodic Migraine Frequency
- Worldwide Migraine Incidence Shifting From Teens to Middle-Aged Patients
- Anticalcitonin Gene-Related Peptide Agents Effectively Prevent Migraines
- Ictal, Perictal Migraine Pain Linked With Motor Impairment
Clinical Tools
Powered by
Powered by 
